Indeed, administration of this drug to rats bearing 9 L gliosarcoma cells significantly increased the level of EAAT2 and the number of neurons in peritumoral tissue, as well as decreased tumor size and extend survival of animals [103]. The gene discussed is SLC1A2; the disease is neoplasm.